Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.

doi:10.1158/0008-5472.CAN-20-0977

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.

Cancer research - 15 Oct 2020

Bellmunt Joaquim, Kim Jaegil, Reardon Brendan, Perera-Bel Júlia, Orsola Anna, Rodriguez-Vida Alejo, Wankowicz Stephanie A, Bowden Michaela, Barletta Justine A, Morote Juan, de Torres Inés, Juanpere Nuria, Lloreta-Trull Josep, Hernandez Silvia, Mouw Kent W, Taplin Mary-Ellen, Cejas Paloma, Long Henry W, Van Allen Eliezer M, Getz Gad, Kwiatkowski David J

Abstract excerpt

High-grade T1 (HGT1) bladder cancer is the highest risk subtype of non-muscle-invasive bladder cancer with unpredictable outcome and poorly understood risk factors. Here, we examined the association of somatic mutation profiles with nonrecurrent disease (GO, good outcome), recurrence (R), or progression (PD) in a cohort of HGT1 patients. Exome sequencing was performed on 62 HGT1 and 15 matched normal tissue...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin E

Share to Gene Dosage

Share to Muscles

Share to Neoplasm Recurrence, Local

Share to Oncogene Proteins

Share to Urinary Bladder Neoplasms

Share to Xeroderma Pigmentosum Group D Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 32868381
DOI: 10.1158/0008-5472.CAN-20-0977
PMCID: PMC9361191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.PMID 32868381Read ↗

Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomesSemantic proximity Read ↗

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancerSemantic proximity Read ↗

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.Semantic proximity Read ↗

Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer.Semantic proximity Read ↗

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read ↗

Molecular Profiling of Bladder Adenocarcinoma Using a National Genomics RepositorySemantic proximity Read ↗

Epigenomic analysis of high-grade T1 bladder cancer reveals subtypes with clinical implications that display extensive intra-tumor heterogeneity with spatial features.Semantic proximity Read ↗

Clinical and genomic profiling of early-onset bladder cancer identifies key alterations and therapeutic targetsSemantic proximity Read ↗

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.Semantic proximity Read ↗

Molecular profile of bladder cancer progression to clinically aggressive subtypesSemantic proximity Read ↗

Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.